Compounds > rc 3095
Page last updated: 2024-09-03

rc 3095 and bombesin(6-14), hca(6)-leu(13)-psi(ch2n)-tac(14)-

rc 3095 has been researched along with bombesin(6-14), hca(6)-leu(13)-psi(ch2n)-tac(14)- in 8 studies

Compound Research Comparison

Studies
(rc 3095)		Trials
(rc 3095)		Recent Studies (post-2010)
(rc 3095)		Studies
(bombesin(6-14), hca(6)-leu(13)-psi(ch2n)-tac(14)-)		Trials
(bombesin(6-14), hca(6)-leu(13)-psi(ch2n)-tac(14)-)		Recent Studies (post-2010) (bombesin(6-14), hca(6)-leu(13)-psi(ch2n)-tac(14)-)
1082262203

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (50.00)18.2507
2000's4 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, RZ; Ertl, T; Groot, K; Horvàth, JE; Qin, Y; Schally, AV1
Cai, RZ; Groot, K; Halmos, G; Lamharzi, N; Miyazaki, M; Schally, AV; Szepeshazi, K1
Arencibia, JM; Halmos, G; Koppán, M; Lamharzi, N; Schally, AV1
Armatis, P; Groot, K; Kiaris, H; Schally, AV; Sun, B1
Arencibia, JM; Cai, RZ; Groot, K; Halmos, G; Kahán, Z; Schally, AV; Sun, B1
Armatis, P; Chatzistamou, I; Schally, AV; Sun, B; Szepeshazi, K1
Bajo, AM; Groot, K; Hebert, F; Krupa, M; Schally, AV; Szepeshazi, K1
Bajo, AM; Groot, K; Schally, AV; Szepeshazi, K1

Other Studies

8 other study(ies) available for rc 3095 and bombesin(6-14), hca(6)-leu(13)-psi(ch2n)-tac(14)-

ArticleYear
Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP.
    International journal of cancer, 1995, Oct-09, Volume: 63, Issue:2

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bombesin; Cell Division; Cyclic AMP; Gastrin-Releasing Peptide; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms; Peptide Fragments; Peptides; Tumor Cells, Cultured

1995
Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095.
    European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:5

    Topics: Animals; Antineoplastic Agents; Blotting, Southern; Bombesin; Breast Neoplasms; Cell Division; ErbB Receptors; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Peptide Fragments; Polymerase Chain Reaction; Radioimmunoassay; Receptors, Bombesin; Receptors, Cholecystokinin; RNA, Messenger; Transplantation, Heterologous

1998
Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma.
    Cancer, 1998, Oct-01, Volume: 83, Issue:7

    Topics: Animals; Anticarcinogenic Agents; Antigens, Neoplasm; Antineoplastic Agents; Blotting, Southern; Bombesin; Carcinoma, Small Cell; ErbB Receptors; Gastrin-Releasing Peptide; Lung Neoplasms; Male; Membrane Glycoproteins; Mice; Mice, Nude; Neoplasm Transplantation; Peptide Fragments; Polymerase Chain Reaction; RNA, Messenger; Transplantation, Heterologous; Tumor Cells, Cultured

1998
Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide.
    Oncogene, 1999, Nov-25, Volume: 18, Issue:50

    Topics: Animals; Base Sequence; Bombesin; Brain Neoplasms; Cell Division; DNA Primers; Gastrin-Releasing Peptide; Glioblastoma; Humans; Mice; Mice, Nude; Peptide Fragments; Proto-Oncogene Proteins c-fos; RNA, Messenger

1999
Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II.
    Cancer, 2000, Mar-15, Volume: 88, Issue:6

    Topics: Animals; Antineoplastic Agents; Bombesin; Breast Neoplasms; Carcinoma; Dose-Response Relationship, Drug; ErbB Receptors; Female; Gastrin-Releasing Peptide; Gene Expression Regulation, Neoplastic; Humans; Injections, Subcutaneous; Mice; Mice, Nude; Neoplasm Transplantation; Neurokinin B; Peptide Fragments; Polymerase Chain Reaction; Receptors, Bombesin; Remission Induction; RNA, Messenger; Transplantation, Heterologous; Tumor Cells, Cultured

2000
Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists.
    British journal of cancer, 2000, Volume: 83, Issue:7

    Topics: Animals; Antineoplastic Agents; Bombesin; Cell Division; Epithelium; Female; Gastrin-Releasing Peptide; Gene Expression; Genes, fos; Genes, jun; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Peptide Fragments; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Receptors, Bombesin; RNA, Messenger; Tumor Cells, Cultured

2000
Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Mar-19, Volume: 99, Issue:6

    Topics: Adult; Animals; Bombesin; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Epidermal Growth Factor; Estrogens; Female; Gastrins; Gene Expression Regulation, Neoplastic; Genes, fos; Genes, jun; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Peptide Fragments; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Receptor, ErbB-2; RNA, Messenger; Tumor Cells, Cultured

2002
Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers.
    British journal of cancer, 2004, Jan-12, Volume: 90, Issue:1

    Topics: Animals; Antineoplastic Agents; Bombesin; Breast Neoplasms; Female; Fibroblast Growth Factors; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Peptide Fragments; RNA, Messenger; Somatomedins; Transplantation, Heterologous; Vascular Endothelial Growth Factor A

2004